BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1626182)

  • 1. Serous ovarian cyst fluids contain high levels of endometrial placental protein 14.
    Riittinen L
    Tumour Biol; 1992; 13(3):175-9. PubMed ID: 1626182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-resolved immunofluorometric assay for placental protein 14.
    Riittinen L; Stenman UH; Alfthan H; Suikkari AM; Bohn H; Seppälä M
    Clin Chim Acta; 1989 Aug; 183(2):115-23. PubMed ID: 2676243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies against endometrial protein PP14 and their use for purification and radioimmunoassay of PP14.
    Riittinen L; Närvänen O; Virtanen I; Seppälä M
    J Immunol Methods; 1991 Jan; 136(1):85-90. PubMed ID: 1995715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of placental protein 14 in tissues and body fluids during pregnancy.
    Julkunen M; Rutanen EM; Koskimies A; Ranta T; Bohn H; Seppälä M
    Br J Obstet Gynaecol; 1985 Nov; 92(11):1145-51. PubMed ID: 4063232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental protein 10: levels in benign and malignant ovarian cyst fluids and pleural exudates.
    Than G; Tiitinen A; Seppälä M; Csaba I; Bohn H
    Arch Gynecol; 1987; 240(2):115-8. PubMed ID: 3566356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental protein 5 in benign and malignant ovarian cyst fluids.
    Than G; Seppälä M; Csaba I; Iino K; Briese V
    Tumour Biol; 1987; 8(4):230-1. PubMed ID: 3448769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural studies, localization in tissue and clinical aspects of human endometrial proteins.
    Seppälä M; Riittinen L; Julkunen M; Koistinen R; Wahlström T; Iino K; Alfthan H; Stenman UH; Huhtala ML
    J Reprod Fertil Suppl; 1988; 36():127-41. PubMed ID: 3057195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of glycodelin A in fluids of benign ovarian cysts, borderline tumours and malignant ovarian cancer.
    Bischof A; Briese V; Richter DU; Bergemann C; Friese K; Jeschke U
    Anticancer Res; 2005; 25(3A):1639-44. PubMed ID: 16033074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of endometrial protein PP14 from mid-trimester amniotic fluid.
    Riittinen L; Julkunen M; Seppälä M; Koistinen R; Huhtala ML
    Clin Chim Acta; 1989 Sep; 184(1):19-29. PubMed ID: 2688994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The measurement of CA 125 and placental protein 14 in uterine flushings in women with recurrent miscarriage; relation to endometrial morphology.
    Dalton CF; Laird SM; Serle E; Saravelos H; Warren MA; Li TC; Bolton AE
    Hum Reprod; 1995 Oct; 10(10):2680-4. PubMed ID: 8567792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the ovary in the synthesis of placental protein-14.
    Critchley HO; Chard T; Olajide F; Davies MC; Hughes S; Wang HS; Lieberman BA; Anderson DC
    J Clin Endocrinol Metab; 1992 Jul; 75(1):97-100. PubMed ID: 1619035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial protein PP14 and CA-125 in recurrent miscarriage patients; correlation with pregnancy outcome.
    Dalton CF; Laird SM; Estdale SE; Saravelos HG; Li TC
    Hum Reprod; 1998 Nov; 13(11):3197-202. PubMed ID: 9853880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in concentrations of the major endometrial secretory proteins (placental protein 14 and insulin-like growth factor binding protein-1) in assisted conception regimes.
    Arthur ID; Anthony FW; Chard T; Masson GM; Thomas EJ
    Hum Reprod; 1995 Mar; 10(3):664-7. PubMed ID: 7540180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human endometrial proteins.
    Seppälä M; Suikkari AM; Julkunen M
    Reprod Nutr Dev (1980); 1988; 28(6B):1649-54. PubMed ID: 2854652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumors.
    Jeschke U; Bischof A; Speer R; Briese V; Richter DU; Bergemann C; Mylonas I; Shabani N; Friese K; Karsten U
    Anticancer Res; 2005; 25(3A):1581-9. PubMed ID: 16033064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal human ovary and ovarian tumors express glycodelin, a glycoprotein with immunosuppressive and contraceptive properties.
    Kämäräinen M; Leivo I; Koistinen R; Julkunen M; Karvonen U; Rutanen EM; Seppälä M
    Am J Pathol; 1996 May; 148(5):1435-43. PubMed ID: 8623915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dramatic increase in levels of placental protein 14 in amniotic fluid at 10-15 weeks' pregnancy.
    Chatzakis K; Wathen N; Campbell J; Iles R; Dawnay A; Chard T
    Early Hum Dev; 1994 Feb; 36(2):113-6. PubMed ID: 8200319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and localization of placental protein 14-like protein in human seminal plasma and in the male genital tract.
    Julkunen M; Wahlström T; Seppälä M; Koistinen R; Koskimies A; Stenman UH; Bohn H
    Arch Androl; 1984; 12 Suppl():59-67. PubMed ID: 6398989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyst fluid of ovarian cancer patients contains high concentrations of trypsinogen-2.
    Koivunen E; Itkonen O; Halila H; Stenman UH
    Cancer Res; 1990 Apr; 50(8):2375-8. PubMed ID: 2180568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta lactoglobulin homologue placental protein 14 (PP14) in serum of patients with trophoblastic disease and non-trophoblastic gynecologic malignancy.
    Than GN; Tatra G; Szabó DG; Csaba IF; Bohn H
    Arch Gynecol Obstet; 1988; 243(3):131-7. PubMed ID: 2844125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.